This Month's MagazineDining and SpiritsArts and EntertainmentTravel and LeisureHome and Real EstateHealth and WellnessShopping & FashionEvents and PicsElegant Wedding Magazine

Bookmark and share

Issue Date: March 2014 Issue

Best Doctors 2014: Replacement Arts

Dr. Soon Park brings his expertise of treating ailing hearts to University Hospitals.
Jennifer Keirn

While an undergrad at the University of Chicago, Dr. Soon Park watched his sister, only in her late 20s, suffer from end-stage kidney disease that caused her to endure dialysis treatments three days a week until finally receiving a new kidney. That experience got Park hooked on what he calls "the miracle of transplantation." Known for his work on the landmark 2000 clinical trial that found increased survival rates in patients with ventricular assist devices, Park left the Mayo Clinic in October to become University Hospitals' chief of cardiac surgery and co-director of its Harrington Heart and Vascular Institute. The doctor talks to us about his 30-year career focused on finding new therapies to treat failing hearts and the future of heart care.

Q. What has been your primary research interest over your career?

A. Whatever means we can employ to replacing failing hearts is what I'm interested in. When dealing with a bad heart, I look at multiple options: medical therapies, new devices, conventional surgery, ventricular assist devices or transplantation. We think that easily 10,000 to 100,000 people a year need a heart replacement. With limited hearts, transplant is a very good therapy but it helps a very small portion of that population. With VADs, we can improve the quality of life and survival of these patients immensely.

Q. What kind of research have you been involved in to increase the options for heart replacement?

A. At the Mayo Clinic, I was involved in exploring transplants of hearts from genetically modified pigs as a potential organ source for treating patients with heart failure. That's in the basic scientific research phase. I've also been involved in clinical trials testing the latest generation of VADs. They are good therapies for people with dilated cardiomyopathy [oversized heart chambers], but people with restrictive cardiomyopathy [stiff heart chambers] have had very limited options. We're involved in pushing the frontier of VAD therapy into other patient populations.

Q. What most excites you among new innovations in heart care?

A. VADs will improve dramatically over the next five to 10 years. They will be smaller, less bulky and totally implantable [without power cords through the skin]. Current systems last about five to seven years, but the newer generation will probably last 10-plus years. That's an exciting thing.

Wednesday, February 26, 2014 10:16:38 AM by Anonymous
As a former patient of Dr. Park, I would happily wish to add what it is like to be on the receiving end of his talent and abilities. It was his skills that allowed me to have a much improved life following a discovery of a potential killer blockage (which I totally believed to be nothing more that a backbone stenosis as that was pretty much all that hurt...). Yet the work that Dr. Park performed was excellent and I am happily hitting the mile and a half track now. Dr. Park is very courteous and well spoken. He takes time to explain in depth what was done and how the operation was performed. A fine doctor all around.
Thursday, February 27, 2014 5:10:56 PM by Anonymous
Dr. Park is truly amazing! So thankful and blessed to have you here in Cleveland.

Comments. All comments must be approved by our editorial staff.
Choose an identity
Other Anonymous
All of these fields are optional.
CAPTCHA Validation
Retype the code from the picture
CAPTCHA Code Image
Speak the code Change the code

Home | Subscribe | Archives | Advertise | Newsstands | Contact Us | Jobs | Legal
© Cleveland Magazine 2014 | P: (216) 771-2833 | F: (216) 781-6318 | 1422 Euclid Ave. Suite 730 Cleveland, Ohio 44115
This site is a member of the City & Regional Magazine Association